Marilyn L. Slovak

21.0k total citations · 5 hit papers
152 papers, 11.7k citations indexed

About

Marilyn L. Slovak is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Marilyn L. Slovak has authored 152 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Hematology, 53 papers in Molecular Biology and 35 papers in Genetics. Recurrent topics in Marilyn L. Slovak's work include Acute Myeloid Leukemia Research (75 papers), Chronic Myeloid Leukemia Treatments (32 papers) and Acute Lymphoblastic Leukemia research (32 papers). Marilyn L. Slovak is often cited by papers focused on Acute Myeloid Leukemia Research (75 papers), Chronic Myeloid Leukemia Treatments (32 papers) and Acute Lymphoblastic Leukemia research (32 papers). Marilyn L. Slovak collaborates with scholars based in United States, Canada and Sweden. Marilyn L. Slovak's co-authors include Frederick R. Appelbaum, Cheryl L. Willman, Kenneth J. Kopecky, David R. Head, Stephen J. Forman, John E. Godwin, Daniel A. Arber, Holly Gundacker, Stephen H. Petersdorf and Jeanne E. Anderson and has published in prestigious journals such as Science, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Marilyn L. Slovak

151 papers receiving 11.4k citations

Hit Papers

Karyotypic analysis predicts outcome of preremission and ... 1995 2026 2005 2015 2000 2006 1997 1995 2013 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
    2000 1.2k citations Marilyn L. Slovak, Kenneth J. Kopecky et al. Blood profile →
  2. Age and acute myeloid leukemia
    2006 982 citations Frederick R. Appelbaum, David R. Head et al. Blood profile →
  3. Acute Myeloid Leukemia in the Elderly: Assessment of Multidrug Resistance (MDR1) and Cytogenetics Distinguishes Biologic Subgroups With Remarkably Distinct Responses to Standard Chemotherapy. A Southwest Oncology Group Study
    1997 696 citations Catherine P. Leith, Kenneth J. Kopecky et al. Blood profile →
  4. The drug resistance-related protein LRP is the human major vault protein
    1995 512 citations George L. Scheffer, Peter Wijngaard et al. Nature Medicine profile →
  5. A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia
    2013 460 citations Kenneth J. Kopecky, Marilyn L. Slovak et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marilyn L. Slovak United States 46 6.9k 4.4k 4.0k 2.8k 2.3k 152 11.7k
Elisabeth Paietta United States 61 7.8k 1.1× 4.7k 1.1× 3.0k 0.7× 4.3k 1.6× 2.6k 1.1× 278 12.9k
Norbert Ifrah France 52 7.3k 1.1× 3.9k 0.9× 3.5k 0.9× 2.8k 1.0× 1.7k 0.8× 231 11.4k
Oliver G. Ottmann Germany 62 10.4k 1.5× 4.9k 1.1× 4.0k 1.0× 3.3k 1.2× 5.0k 2.2× 372 16.1k
Claus R. Bartram Germany 48 4.1k 0.6× 3.8k 0.9× 1.7k 0.4× 2.9k 1.0× 2.1k 0.9× 212 10.0k
Nigel H. Russell United Kingdom 57 8.9k 1.3× 4.4k 1.0× 3.3k 0.8× 2.5k 0.9× 2.5k 1.1× 355 12.4k
Gert J. Ossenkoppele Netherlands 53 8.6k 1.3× 4.4k 1.0× 2.8k 0.7× 2.3k 0.8× 2.8k 1.2× 279 12.3k
Tapan M. Kadia United States 57 9.8k 1.4× 5.4k 1.2× 2.7k 0.7× 3.0k 1.1× 3.9k 1.7× 778 13.2k
Peter L. Greenberg United States 45 9.1k 1.3× 3.2k 0.7× 1.7k 0.4× 1.4k 0.5× 3.8k 1.7× 203 11.0k
Christian Thiede Germany 56 6.7k 1.0× 3.7k 0.8× 2.2k 0.5× 1.7k 0.6× 2.7k 1.2× 268 12.1k
Claude Preudhomme France 62 9.4k 1.4× 5.7k 1.3× 2.4k 0.6× 2.4k 0.9× 4.4k 1.9× 356 13.3k

Countries citing papers authored by Marilyn L. Slovak

Since Specialization
Citations

This map shows the geographic impact of Marilyn L. Slovak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilyn L. Slovak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilyn L. Slovak more than expected).

Fields of papers citing papers by Marilyn L. Slovak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilyn L. Slovak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilyn L. Slovak. The network helps show where Marilyn L. Slovak may publish in the future.

Co-authorship network of co-authors of Marilyn L. Slovak

This figure shows the co-authorship network connecting the top 25 collaborators of Marilyn L. Slovak. A scholar is included among the top collaborators of Marilyn L. Slovak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilyn L. Slovak. Marilyn L. Slovak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Slovak, Marilyn L., Victoria Bedell, Ya‐Hsuan Hsu, et al.. (2011). Molecular Karyotypes of Hodgkin and Reed–Sternberg Cells at Disease Onset Reveal Distinct Copy Number Alterations in Chemosensitive versus Refractory Hodgkin Lymphoma. Clinical Cancer Research. 17(10). 3443–3454. 38 indexed citations
2.
Kolquist, Kathryn A., Roger A. Schultz, Theresa C. Brown, et al.. (2011). Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes. Cancer Genetics. 204(11). 603–628. 45 indexed citations
3.
Pullarkat, Vinod, Marilyn L. Slovak, Andrew Dagis, et al.. (2009). Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation. Annals of Oncology. 20(12). 2000–2006. 11 indexed citations
4.
Shih, Chu-Chih, Stephen J. Forman, Peiguo Chu, & Marilyn L. Slovak. (2007). Human Embryonic Stem Cells Are Prone to Generate Primitive, Undifferentiated Tumors in Engrafted Human Fetal Tissues in Severe Combined Immunodeficient Mice. Stem Cells and Development. 16(6). 893–902. 81 indexed citations
5.
Тодоров, Иван, et al.. (2007). Human Marrow-Derived Mesodermal Progenitor Cells Generate Insulin-Secreting Islet-Like Clusters In Vivo. Stem Cells and Development. 16(5). 757–770. 17 indexed citations
6.
Pullarkat, Vinod, Marilyn L. Slovak, Kenneth J. Kopecky, Stephen J. Forman, & Frederick R. Appelbaum. (2007). Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study. Blood. 111(5). 2563–2572. 157 indexed citations
7.
Wolman, Sandra R., Bryan Goldman, Marilyn L. Slovak, et al.. (2007). Aneusomy for detection of bladder cancer recurrence: a Southwest Oncology Group study. Cancer Genetics and Cytogenetics. 176(1). 22–27. 4 indexed citations
8.
Huang, Qin, Yaping Wu, David S. Snyder, et al.. (2007). Clinical and Pathologic Analysis of 16 Cases of Relapsed Chronic Myeloid Leukemia After Stem Cell Transplantation. American Journal of Clinical Pathology. 128(4). 565–570. 5 indexed citations
9.
Chow, Warren, Victoria Bedell, Ernest C. Borden, et al.. (2006). Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas. Cancer Genetics and Cytogenetics. 166(2). 95–100. 15 indexed citations
10.
Zhao, Xiaohui, Qin Huang, Marilyn L. Slovak, & Lawrence M. Weiss. (2005). Comparison of Ancillary Studies in the Detection of Residual Disease in Plasma Cell Myeloma in Bone Marrow. American Journal of Clinical Pathology. 125(6). 895–904. 14 indexed citations
11.
Snyder, David S., et al.. (2004). Chronic myeloid leukemia with an e13a3 BCR‐ABL fusion: Benign course responsive to imatinib with an RT‐PCR advisory. American Journal of Hematology. 75(2). 92–95. 26 indexed citations
12.
Arber, Daniel A., David S. Snyder, Miriam Fine, et al.. (2001). Myeloperoxidase Immunoreactivity in Adult Acute Lymphoblastic Leukemia. American Journal of Clinical Pathology. 116(1). 25–33. 29 indexed citations
13.
Jensen, Michael C., Christine L. Wright, Feiyu Zhang, et al.. (2000). Human T Lymphocyte Genetic Modification with Naked DNA. Molecular Therapy. 1(1). 49–55. 87 indexed citations
14.
Krishnan, Amrita, Ravi Bhatia, Marilyn L. Slovak, et al.. (2000). Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood. 95(5). 1588–1593. 205 indexed citations
15.
16.
Khalidi, Hasan S., RK Brynes, L. Jeffrey Medeiros, et al.. (1998). The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.. PubMed. 11(12). 1211–21. 33 indexed citations
17.
Slovak, Marilyn L., S. Thomas Traweek, Cheryl L. Willman, et al.. (1995). Trisomy 11: an association with stem/progenitor cell immunophenotype. British Journal of Haematology. 90(2). 266–273. 34 indexed citations
18.
Scheffer, George L., Peter Wijngaard, Marcel J. Flens, et al.. (1995). The drug resistance-related protein LRP is the human major vault protein. Nature Medicine. 1(6). 578–582. 512 indexed citations breakdown →
19.
Willman, Cheryl L., Cordelia E. Sever, Maria G. Pallavicini, et al.. (1993). Deletion of IRF-1 , Mapping to Chromosome 5q31.1, in Human Leukemia and Preleukemic Myelodysplasia. Science. 259(5097). 968–971. 335 indexed citations
20.
Slovak, Marilyn L., Gerald A. Hoeltge, William S. Dalton, & Jeffrey M. Trent. (1988). Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines.. PubMed. 48(10). 2793–7. 144 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elisabeth Paietta Breakdown of academic impact, for papers by Norbert Ifrah Breakdown of academic impact, for papers by Oliver G. Ottmann Breakdown of academic impact, for papers by Claus R. Bartram Breakdown of academic impact, for papers by Nigel H. Russell Breakdown of academic impact, for papers by Gert J. Ossenkoppele Breakdown of academic impact, for papers by Tapan M. Kadia Breakdown of academic impact, for papers by Peter L. Greenberg Breakdown of academic impact, for papers by Christian Thiede Breakdown of academic impact, for papers by Claude Preudhomme
Rankless by CCL
2026